Report: Johnson & Johnson negotiating deal to buy partner Pharmacyclics for more than $17B
March 04, 2015 at 17:32 PM EST
Health care giant Johnson & Johnson reportedly is close to buying biopharmaceutical company Pharmacyclics, its longtime partner in developing blood cancer treatment Imbruvica.
